Window to brain's reward system could lead to better treatments for alcoholism

March 20, 2017 by Ryan O'hare
Credit: Imperial College London

Scanning the brains of alcoholics taking medication to beat their addiction has revealed new insights into how the treatments work.

In a small trial, carried out at Imperial College London, researchers have provided a unique view into the brains of active alcoholics taking a newly licensed treatment, showing that the medication blunts the brain's reward pathway.

The team believes the findings could help to improve existing drug treatments for alcoholism by targeting them to those who are most likely to benefit, and even lead to the development of more effective treatments.

Led by Professor Anne Lingford-Hughes, a consultant psychiatrist and addiction expert in Imperial's Department of Medicine, the group set out to explore the effects of nalmefene – a compound which modulates opioid receptors in the brain – in alcoholics.

Nalmefene has been successfully shown to treat alcoholism and also pathological gambling. It appears to work by effectively dulling the desire for alcohol, or the need for a 'win', but exactly how it affected the brain was unclear.

Now, findings from the Imperial team's latest study suggest that the drug blunts the response in key areas of the brain involved in habit formation. The researchers believe nalmefene effectively reduces the anticipation of alcohol by interfering with the brain's dopamine-based reward systems.

"The findings indicate that the mechanism proposed to explain how the drug works is correct," said Professor Lingford-Hughes. "Certainly this fits with my clinical experience, where people describe how being on these opiate blocking drugs means that they may start drinking, but then they just don't want any more – they don't crave it, they don't desire it, it doesn't taste nice or give them a good feeling."

Blunting the reward system

In the latest study, published in the journal Biological Psychiatry, the team recruited 22 alcoholics who were not currently seeking treatment to see the effect of nalmefene. The volunteers were asked to perform tasks in an MRI scanner and were administered the single dose of the drug, equivalent to what they would receive in the real world setting (18 mg).

As part of a classic reward anticipation set up, participants were shown a screen with symbols flashing up, some of which meant they would win a small cash reward.

Throughout the task, snapshots of their brain activity were taken using the fMRI, highlighting when they were anticipating the reward.

However, unlike other studies, the volunteers were under the influence of alcohol, receiving an intravenous infusion to bring their blood-alcohol levels up to the English drink drive limit (80 mg per 100 mL of blood).

Scans revealed that when patients took nalmefene with alcohol, activity in two areas of the brain, the dorsal and ventral striatum, decreased.

Neuroscientists believe that these regions are key in habit-formation, with activity shifting from the ventral to the dorsal region as the habit develops. But in the heavy drinking volunteers, the feedback system was dampened down by nalmefene, which was linked with reduced anticipation of a reward.

Professor Lingford-Hughes explained: "We are trying to understand the underlying brain mechanisms in addiction and one of the ways of doing this is that if you know a can help people, you can look at what it is doing to brain processes and see what it is modulating."

The team believes that not only could the work lead to better targeting of existing drugs, it could also help to develop new drug treatments for alcoholism. They stress that one of the limitations of the study is the lack of a control scan, where the volunteers would have been imaged without the influence of alcohol.

However, previous studies testing similar drugs in patients who were not under the influence of alcohol showed a lack of modulation of brain pathways, hinting that the treatments are most effective in the presence of alcohol - something consistent with clinical findings.

"What our findings show is that if patients have been pre-treated with this , we blunt the response to that monetary reward, so they seem to be getting less activation to the rewarding stimulus," added Professor Lingford-Hughes.

"We can infer from that that it may be helpful in blunting the drive that makes them want more of the same thing – such as ­– and is consistent with the hypothesis on how the drugs work, by activating the system less."

Explore further: Addicted individuals less responsive to reward-anticipation

More information: Darren R. Quelch et al. Nalmefene Reduces Reward Anticipation in Alcohol Dependence: An Experimental Functional Magnetic Resonance Imaging Study, Biological Psychiatry (2017). DOI: 10.1016/j.biopsych.2016.12.029

Related Stories

Addicted individuals less responsive to reward-anticipation

February 2, 2017
It may be difficult for addicted individuals to learn when they can expect a reward. This learning problem could perhaps explain why they are more prone to addiction and find it difficult to kick the habit. Researchers at ...

Gambling addiction triggers the same brain areas as drug and alcohol cravings

January 3, 2017
Gambling addiction activates the same brain pathways as drug and alcohol cravings, suggests new research.

Institute recommends brief counselling and as-needed nalmefene to help people with alcohol dependence

October 6, 2014
The drug nalmefene, which can help people dependent on alcohol cut down on the amount they drink, has been recommended in final draft guidance by the National Institute for Health and Care Excellence (NICE).

Meta-analysis finds evidence for nalmefene in the treatment of alcohol dependence is weak

December 22, 2015
Currently available evidence from randomized controlled trials (RCT) does not support the use of nalmefene for harm reduction for people with alcohol dependence, according to a systematic review and meta-analysis (SRMA) published ...

Brain mechanisms in drug addiction—new brain pathways revealed

November 24, 2016
UNSW researchers have identified new brain pathways linked to addiction and shown that by manipulating them, drug seeking behaviour and motivation for alcohol can be reduced.

Weak evidence for prescribed alcohol drug, say scientists

June 6, 2016
A drug being used to treat alcohol problems in the UK was licensed for use despite insufficient evidence to prove its effectiveness, new research led by the University of Stirling has found.

Recommended for you

For a better 'I,' there needs to be a supportive 'we'

September 25, 2017
If you're one of those lucky individuals with high motivation and who actively pursues personal growth goals, thank your family and friends who support you.

Babies can learn that hard work pays off

September 21, 2017
If at first you don't succeed, try, try again. A new study from MIT reveals that babies as young as 15 months can learn to follow this advice. The researchers found that babies who watched an adult struggle at two different ...

Study links brain inflammation to suicidal thinking in depression

September 21, 2017
Patients with major depressive disorder (MDD) have increased brain levels of a marker of microglial activation, a sign of inflammation, according to a new study in Biological Psychiatry by researchers at the University of ...

Oxytocin turns up the volume of your social environment

September 20, 2017
Before you shop for the "cuddle" hormone oxytocin to relieve stress and enhance your social life, read this: a new study from the University of California, Davis, suggests that sometimes, blocking the action of oxytocin in ...

Researchers develop new tool to assess individual's level of wisdom

September 20, 2017
Researchers at University of San Diego School of Medicine have developed a new tool called the San Diego Wisdom Scale (SD-WISE) to assess an individual's level of wisdom, based upon a conceptualization of wisdom as a trait ...

Alcohol use affects levels of cholesterol regulator through epigenetics

September 20, 2017
In an analysis of the epigenomes of people and mice, researchers at Johns Hopkins Medicine and the National Institutes of Health report that drinking alcohol may induce changes to a cholesterol-regulating gene.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.